IRIS
BRAVACCINI, SARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 880
EU - Europa 637
NA - Nord America 603
SA - Sud America 258
AF - Africa 9
OC - Oceania 2
Totale 2.389
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 578
SG - Singapore 419
HK - Hong Kong 368
IE - Irlanda 311
BR - Brasile 244
DE - Germania 73
IT - Italia 66
TR - Turchia 50
FR - Francia 38
NL - Olanda 30
FI - Finlandia 24
GB - Regno Unito 22
RU - Federazione Russa 18
CA - Canada 13
AT - Austria 12
MX - Messico 11
IN - India 9
LT - Lituania 9
IQ - Iraq 8
BE - Belgio 6
CZ - Repubblica Ceca 6
AR - Argentina 5
CN - Cina 5
UZ - Uzbekistan 5
BD - Bangladesh 4
ES - Italia 4
PL - Polonia 4
CO - Colombia 3
SE - Svezia 3
TN - Tunisia 3
UA - Ucraina 3
VE - Venezuela 3
ZA - Sudafrica 3
AL - Albania 2
AU - Australia 2
AZ - Azerbaigian 2
EC - Ecuador 2
JP - Giappone 2
KG - Kirghizistan 2
RS - Serbia 2
SA - Arabia Saudita 2
SN - Senegal 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
CH - Svizzera 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
MA - Marocco 1
PK - Pakistan 1
PY - Paraguay 1
TT - Trinidad e Tobago 1
VN - Vietnam 1
Totale 2.389
Salva come PNG Salva come JPEG
Città #
Hong Kong 366
Dublin 311
Singapore 192
Santa Clara 135
Boardman 129
The Dalles 88
Istanbul 43
Munich 27
Helsinki 22
Amsterdam 21
São Paulo 21
Ashburn 19
Assago 18
Frankfurt am Main 16
Los Angeles 12
Chicago 10
Milan 10
Düsseldorf 9
Vienna 9
Belo Horizonte 8
San Francisco 8
Rio de Janeiro 7
Boston 6
Brno 6
Brussels 6
Paris 6
Bexley 5
Brasília 5
Brooklyn 5
Lugo 5
Mexico City 5
New York 5
Toronto 5
Atlanta 4
Campinas 4
Guarulhos 4
Juiz de Fora 4
Ottawa 4
Porto Alegre 4
Tashkent 4
Ankara 3
Betim 3
Birmingham 3
Lauterbourg 3
London 3
Manchester 3
Montreal 3
Palhoça 3
Pescara 3
Portsmouth 3
Ribeirão Preto 3
Rome 3
Santo André 3
Stockholm 3
São Sebastião do Paraíso 3
Viamão 3
Warsaw 3
Americana 2
Apodi 2
Avaré 2
Baku 2
Basra 2
Belgrade 2
Bishkek 2
Bogotá 2
Caxias do Sul 2
Chennai 2
Contagem 2
Curitiba 2
Dakar 2
Dallas 2
Garanhuns 2
Hortolândia 2
Houston 2
Itajubá 2
Itapema 2
João Pessoa 2
Lecce 2
Limeira 2
Maricá 2
Misilmeri 2
New Delhi 2
Nova Iguaçu 2
Nuremberg 2
Osasco 2
Pacajus 2
Phoenix 2
Ponsacco 2
Roubaix 2
Salvador 2
Sete Lagoas 2
Sorocaba 2
São Lourenço 2
Tirana 2
Tokyo 2
Turku 2
Virginia Beach 2
Várzea Grande 2
Várzea Paulista 2
Água Boa 2
Totale 1.705
Salva come PNG Salva come JPEG
Nome #
Chronological age or biological age: What drives the choice of adjuvant treatment in elderly breast cancer patients? 71
The use of platelets as a clinical tool in oncology: opportunities and challenges 42
Biomarkers: which ones do we really need today? 40
Urinary Biomarkers in Tumors: An Overview 32
Re: Clinicopathological features and outcomes comparing patients with invasive ductal and lobular breast cancer 31
Appropriateness and Economic Analysis of Conventional Circulating Biomarkers Assessment in Early Breast Cancer: A Real-World Experience from the E.Pic.A Study 30
Atezolizumab Plus Nab-paclitaxel in PD-L1-Positive TNBC-Letter 30
Tumor resident microbiota and response to therapies: An insight on tissue bacterial microbiota 30
Combining preclinical tools and models to unravel tumor complexity: Jump into the next dimension 29
A Novel AKT1, ERBB2, ESR1, KRAS, PIK3CA, and TP53 NGS Assay: A Non-Invasive Tool to Monitor Resistance Mechanisms to Hormonal Therapy and CDK4/6 Inhibitors 28
Evaluating the appropriateness of chemotherapy in a low-resource cancer centre in sub-Saharan Africa 27
TMB in NSCLC: A Broken Dream? 27
T-Cell Receptor Repertoire Sequencing and Its Applications: Focus on Infectious Diseases and Cancer 27
Androgen receptor signaling pathways as a target for breast cancer treatment 26
A functional survey of the regulatory landscape of estrogen-receptor-positive breast cancer evolution 26
Safety and efficacy of anti-PD-1 inhibitors in Chinese patients with advanced lung cancer and hepatitis B virus infection: a retrospective single-center study 26
Ki67 and PR in patients treated with CDK4/6 Inhibitors: A real-world experience 25
Combined Oral Fentanyl Citrate and Midazolam as Premedication for Bone Marrow Aspiration and Biopsy in Patients with Hematological Malignancies: A Randomized, Controlled and Patient-Blinded Clinical Trial 25
Telomerase Activity Analysis In Urine Sediment for Bladder Cancer 25
An H-1 NMR study of the cytarabine degradation in clinical conditions to avoid drug waste, decrease therapy costs and improve patient compliance in acute leukemia 25
An initiative to assess the quality of Tanzanian cervical cancer specimens for HPV and telomerase detection 24
Cell-free DNA detected by "liquid biopsy" as a potential prognostic biomarker in patients with different subtypes of breast cancer 24
Exploring the Relationship Between Humoral and Cellular T Cell Responses Against SARS-CoV-2 in Exposed Individuals From Emilia Romagna Region and COVID-19 Severity 24
Are There Differences in Androgen Receptor Expression in Invasive Breast Cancer in African (Tanzanian) Population in Comparison With the Caucasian (Italian) Population? 24
Are BMI and Negative Hormone Receptors Prognostic Factors in HER2+ Early-stage Breast Cancer? 24
Are Androgen and Estrogen Receptors in DCIS Patients Prognostic Indicators of Relapse Independently of Treatment? 24
Cell-free DNA detected by "liquid biopsy" as a potential prognostic biomarker in early breast cancer 23
Are we ready to use TMB in breast cancer clinical practice? 23
Sacituzumab govitecan: a new opportunity in the treatment of refractory metastatic triple-negative breast cancer 23
Androgen receptor in breast cancer: The "5W" questions 23
Predictive role of multiple gene alterations in response to cetuximab in metastatic colorectal cancer: A single center study 22
What Influences the Choice of Ibrutinib-Rituximab vs Classic Chemoimmunotherapy for Chronic Lymphocytic Leukemia? 22
Usefulness of immunological detection of the human telomerase reverse transcriptase 22
Urinary biomarkers of nonmuscle-invasive bladder cancer: current status and future potential 22
Expanding the Horizon of Multidisciplinarity: Incorporating Biomechanical, Metabolic, and Functional Factors Into Registry-Based Research to Predict Subsequent Risk for Total Knee Arthroplasty 21
NMR-Based Metabolomic Approach Tracks Potential Serum Biomarkers of Disease Progression in Patients with Type 2 Diabetes Mellitus 21
Is Ki67 still a powerful ally in predicting the clinical benefit of anthracyclines for the adjuvant treatment of early breast cancer? 21
Proposed clinical phases for the improvement of personalized treatment of checkpoint inhibitor-related pneumonitis 21
Impressive clinical response to anti-PD-1 therapy in epithelioid mesothelioma with high clonal PD-L1 expression and EML4-ALK rearrangement 21
Androgen and oestrogen receptors as potential prognostic markers for patients with ductal carcinoma insitu treated with surgery and radiotherapy 21
Programmed death ligand 1 expression in early stage, resectable non-small cell lung cancer 21
Why the complications of COVID-19 patients differ in elderly and young cancer patients 21
TROP2 (trophoblast cell-surface antigen 2): a drug target for breast cancer 21
Frequency of actionable alterations in epidermal growth factor receptor (EGFR) wild type non-small cell lung cancer: experience of the Wide Catchment Area of Romagna (AVR) 20
Palbociclib (PD 0332991): targeting the cell cycle machinery in breast cancer 20
Setting Up a Medical Oncology Educational Program in Sub-Saharan Africa 20
Expanding Roles of De Novo Lipogenesis in Breast Cancer 20
Combined analysis of miR-200 family and its significance for breast cancer 20
No more disparities among regions in Italy: recent approval of genomic test reimbursability for early breast cancer patients in the country 20
Relevance of urine telomerase in the diagnosis of bladder cancer 20
International expert consensus on diagnosis and treatment of lung cancer complicated by chronic obstructive pulmonary disease. 20
Sorafenib for the treatment of breast cancer 20
Fluorescence In Situ Hybridization in Urine Samples (UroVysion Kit) 20
Pro-apoptotic effect of a nitric oxide-donating NSAID, NCX 4040, on bladder carcinoma cells 19
Urine telomerase: An important marker in the diagnosis of bladder cancer 19
The Expression of Programmed Death Ligand 1 and Vimentin in Resected Non-Metastatic Non-Small-Cell Lung Cancer: Interplay and Prognostic Effects 19
Trop-2 Therapy in Metastatic Triple-Negative Breast Cancer in Italy: Clinical Opportunity and Regulatory Pitfalls 19
Urine cell-free DNA integrity as a marker for early bladder cancer diagnosis: preliminary data 19
An Italian Real-World Study Highlights the Importance of Some Clinicopathological Characteristics Useful in Identifying Metastatic Breast Cancer Patients Resistant to CDK4/6 Inhibitors and Hormone Therapy 19
Frequency of Actionable Alterations in EGFR wt NSCLC: Experience of the Wide Catchment Area of Romagna (AVR) 19
Emerging Roles of Aldehyde Dehydrogenase Isoforms in Anti-cancer Therapy Resistance 19
Molecular characterization of cytotoxic and drug resistance mechanisms induced by NCX 4040, a novel NO-NSAID, in pancreatic cancer cell lines 19
Accuracy of urine telomerase activity to detect bladder cancer in symptomatic patients 19
CAR T cells targeting options in the fight against multiple myeloma 19
Spotlight on Ki67 as a prognostic marker in early breast cancer: all that glitters may not be gold 19
Spotlight on PSMA as a new theranostic biomarker for bladder cancer 18
In-111-Pentetreotide (OctreoScan) scintigraphy in the staging of small-cell lung cancer: its accuracy and prognostic significance 18
Androgen receptor in breast cancer: A wolf in sheep's clothing? A lesson from prostate cancer 18
International consensus on severe lung cancer-the first edition 18
Significant Advancements and Evolutions in Chimeric Antigen Receptor Design 18
Carbonic Anhydrase XII Expression Is Modulated during Epithelial Mesenchymal Transition and Regulated through Protein Kinase C Signaling 18
Human papillomavirus E6 alters Toll-like receptor 9 transcripts and chemotherapy responses in breast cancer cells in vitro 18
Epithelial-to-mesenchymal transition and EGFR status in NSCLC: the role of vimentin expression 18
Letter to the Editor discussing: Hacker S, Lenz C, Reichert L, Ringseis R, Zentgraf K, Krüger K. Vitamin D status and its determinants in German elite athletes. Eur J Appl Physiol. 2025 Jan 4. doi: 10.1007/s00421-024–05699-6 17
What to look for in cell-free DNA from breast cancer patients 17
Triple negative breast cancer in a poor resource setting in North-Western Tanzania: a preliminary study of 52 patients 17
ALK translocation detection in non-small cell lung cancer cytological samples obtained by TBNA or EBUS-TBNA 17
Follicular Lymphoma Microenvironment Traits Associated with Event-Free Survival 17
The current role of telomerase in the diagnosis of bladder cancer 16
Molecular determinations of EGFR and EML4-ALK on a single slide of NSCLC tissue 16
Androgen receptor in advanced breast cancer: is it useful to predict the efficacy of anti-estrogen therapy? 16
KRAS mutation predict response and outcome in advanced non-small cell lung carcinoma without driver alterations receiving PD-1 blockade immunotherapy combined with platinum-based chemotherapy: a retrospective cohort study from China 16
The Role of CXCR4 in the Prediction of Bone Metastases from Breast Cancer: A Pilot Study 16
Erratum to: Benefit from anthracyclines in relation to biological profiles in early breast cancer 16
Analysis of Genetic Alterations in Tunisian Patients with Lung Adenocarcinoma 16
Androgen Receptor Expression in Breast Cancer: What Differences Between Primary Tumor and Metastases? 16
ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients 16
Easily detectable cytomorphological features to evaluate during ROSE for rapid lung cancer diagnosis: from cytology to histology 15
Biofunctional characteristics of in situ and invasive breast carcinoma 15
Combining cytology, TRAP assay, and FISH analysis for the detection of bladder cancer in symptomatic patients 15
Unraveling the protein kinase C/NDRG1 signaling network in breast cancer. 15
Progress with palbociclib in breast cancer: latest evidence and clinical considerations 15
Evaluation of Androgen Receptor in Relation to Estrogen Receptor (AR/ER) and Progesterone Receptor (AR/PgR): A New Must in Breast Cancer? 15
Predictive role of telomerase activity in the clinical outcome of patients with benign lesions of the uterine cervix or CIN 15
Single-cell transcriptomics reveals multi-step adaptations to endocrine therapy 15
Re: "Evolution of low HER2 expression between early and advanced-stage breast cancer" 15
Benefit from anthracyclines in relation to biological profiles in early breast cancer 15
Assessment of DNA Damage and Telomerase Activity in Exfoliated Urinary Cells as Sensitive and Noninvasive Biomarkers for Early Diagnosis of Bladder Cancer in Ex-Workers of a Rubber Tyres Industry 15
Are fine-needle aspiration biopsy-derived cell blocks a useful surrogate for tissue samples in breast cancer? 15
Paraneoplastic lipase and amylase production in a patient with small-cell lung cancer: case report 14
Totale 2.130
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.876
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.876
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024187 0 0 0 0 0 0 0 0 0 0 0 187
2024/20252.455 264 71 193 57 234 318 149 135 304 299 283 148
Totale 2.642